Comparative Effectiveness of a Fixed-Dose Combination of Losartan + HCTZ Versus Bisoprolol + HCTZ in Patients With Moderate-To-Severe Hypertension: Results of the 6-Month ELIZA Trial
Vascular Health and Risk Management
doi 10.2147/vhrm.s44568
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Unknown
Publisher
Informa UK Limited
